SOUTH SAN FRANCISCO, Calif., April 19, 2018 -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report first quarter financial results on Thursday, May 3, 2018, after the financial markets close.
Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host a conference call at 2:00 p.m. PT (5:00 p.m. ET) on May 3, 2018, to discuss first quarter 2018 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call.
Individuals interested in listening to the conference call may do so by dialing (877) 556-5248 for domestic callers, or (720) 545-0029 for international callers. Please reference Conference ID 7270388. Interested parties may access the live teleconference in the Investors section of the company’s website at http://investors.fluidigm.com/events.cfm. The link will not be active until 1:45 p.m. PT (4:45 p.m. ET) on May 3, 2018.
A telephone replay of the teleconference will be available 90 minutes after the end of the call at (855) 859-2056 (domestic toll-free), or (404) 537-3406 (international toll), Conference ID 7270388. The conference call will also be archived on the Fluidigm Investors page at http://investors.fluidigm.com/.
About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
We use our website (www.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (https://www.facebook.com/fluidigm), and LinkedIn page (https://www.linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.
Contact:
Fluidigm Corporation
Ana Petrovic
Director, Corporate Development and Investor Relations
650 243 6628
[email protected]


SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 



